Employers have a real opportunity to step in, offer these treatments affordably and with dignity, and position themselves as employers of choice. While weighing the choice to cover GLP-1s, employer cost is a significant consideration, Midlam noted
Once your body reaches its ideal maintenance dose, you can expect steady, sustainable results over the long term
The Reagent Diluent selected for use can alter the performance of an immunoassay
Ozempic (semaglutide) and Mounjaro (tirzepatide) are medications to treat adult-onset type 2 diabetes
Ozempic, which is the Novo Nordisk brand name for the medication semiglutide, received U.S
Providing Supporting Documentation To strengthen your case for coverage, providing thorough supporting documentation is vital